Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction

Summary In randomized clinical trials the low-molecular-weight heparin enoxaparin has been shown to reduce ischemic complications in patients with acute ST elevation myocardial infarction (STEMI) treated with fibrinolysis. Little is known about the use and efficacy of enoxaparin in unselected patien...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis and haemostasis 2008, Vol.99 (1), p.150-154
Hauptverfasser:	Zeymer, Uwe, Gitt, Anselm, Jünger, Claus, Bauer, Timm, Heer, Tobias, Koeth, Oliver, Wienbergen, Harm, Zahn, Ralf, Senges, Jochen
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty, Balloon, Coronary Anticoagulants - adverse effects Anticoagulants - therapeutic use Biological and medical sciences Blood coagulation. Blood cells Cardiovascular Biology and Cell Signalling Enoxaparin - adverse effects Enoxaparin - therapeutic use Female Fundamental and applied biological sciences. Psychology Germany Hematologic and hematopoietic diseases Hemorrhage - chemically induced Heparin - adverse effects Heparin - therapeutic use Hospital Mortality Humans Male Medical sciences Middle Aged Molecular and cellular biology Myocardial Infarction - drug therapy Myocardial Infarction - mortality Myocardial Infarction - therapy Odds Ratio Platelet diseases and coagulopathies Registries Research Design Retrospective Studies Risk Assessment Risk Factors Secondary Prevention Thrombolytic Therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!